Increased operating expenses largely contributed to the drop. Total revenue was up 13 percent over 2012, but operating expenses increased 17 percent, from $90.5 million in 2012 to $106.2 million this past quarter, which ended March 31.
More Articles on Devices:
35 Orthopedic & Spine Devices Receive FDA 510(k) Clearance
Medical Device Tax Costs Will Be Absorbed by Companies, Not Passed to Hospitals
Orthofix’s Slumped Spine, Orthopedic Sales Brought 17% Gross Profit Drop in Q1
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
